Klaus Jensen
Keine laufenden Positionen mehr
Karriereverlauf von Klaus Jensen
Ehemalige bekannte Positionen von Klaus Jensen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SANOFI | Corporate Officer/Principal | 01.10.2016 | 01.12.2019 |
| NOVO NORDISK A/S | General Counsel | - | - |
| VIFOR PHARMA | Chief Tech/Sci/R&D Officer | 01.01.2020 | - |
Ausbildung von Klaus Jensen
| Copenhagen Business School | Masters Business Admin |
| University of Copenhagen | Doctorate Degree |
Statistik
International
| Dänemark | 4 |
| Frankreich | 2 |
| Schweiz | 2 |
Operativ
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| SANOFI | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland. | Health Technology |
- Börse
- Insiders
- Klaus Jensen
- Erfahrung
